CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04042402
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:44.524236+00:00
Published At: 2025-05-30T00:00:00+00:00
Record Updated At: 2025-05-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Hyperoxaluria Type 1 (PH1)", "Primary Hyperoxaluria Type 2 (PH2)", "Kidney Diseases", "Urologic Diseases", "Genetic Disease", "Primary Hyperoxaluria Type 3 (PH3)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-30"
protocolSection.identificationModule.nctId: "NCT04042402"
protocolSection.identificationModule.officialTitle: "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.